Posts

AbbVie’s big deal, CAR-T’s risks, & getting a biotech job

This week on the "The Readout LOUD" podcast: Are ADCs having a moment? Is CAR-T ...

STAT+: Radiology captures the tension between AI’s pote...

This year’s meeting of the Radiological Society of North America surfaced the te...

Takeda, Janssen join wearable maker to measure scratchi...

In the latest edition of Health Tech newsletter: Takeda, Janssen team up with Ac...

Do GLP-1s have a future treating alcoholism?

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: AbbVie buys Immunogen, maker of ta...

AbbVie will pay $10 billion for Immunogen, acquiring an approved treatment for o...

STAT+: AbbVie buys Immunogen, maker of targeted cancer ...

AbbVie will pay $10 billion for the biotech firm Immunogen, the company said, ac...

Opinion: Diagnostic tests for rare conditions present a...

Diagnostic tests for rare conditions present a mathematical conundrum.

Disability, Politecnico di Milano experiments with AI t...

Milan, 1 December 2023 – Offering citizens information that promotes physical ac...

When physics meets biology: prion protein orchestrates ...

In a groundbreaking study published in Science Advances, researchers from the Fe...

Brainstorming with a bot

A researcher has just finished writing a scientific paper. She knows her work co...

Researchers have taught an algorithm to ‘taste’

For non-connoisseurs, picking out a bottle of wine can be challenging when scann...

Auburn University invites aspiring physicists to PhD pr...

Auburn University’s Department of Physics is hosting a special meeting targeting...

Social media influencers may affect more than voter opi...

UNIVERSITY PARK, Pa. — If Thanksgiving dinner conversations have turned into hea...

New understanding of oobleck-like fluids contributes to...

If you mix cornstarch and water in the right proportions, you get something that...

Research shows human behavior guided by fast changes in...

What happens in the human brain when we learn from positive and negative experie...

Potential pitfalls when using the Cre-LoxP system in ca...

“One limitation [of Cre-LoxP], the focus of this editorial, is the potential los...